AIM To evaluate the efficacy and tolerability of neoadjuvant hyperfractionated accelerated radiotherapy(HART)and concurrent chemotherapy in patients with locally advanced infraperitoneal rectal cancer.METHODS A total ...AIM To evaluate the efficacy and tolerability of neoadjuvant hyperfractionated accelerated radiotherapy(HART)and concurrent chemotherapy in patients with locally advanced infraperitoneal rectal cancer.METHODS A total of 30 patients with histopathologically confirmed T2-3/N0+infraperitoneal adenocarcinoma of rectum cancer patients received preoperative 42 Gy/1.5 Gy/18 days/bid radiotherapy and continuous infusion of 5-fluorouracil(325 mg/m^2).All patients were operated 4-8 wk after neoadjuvant concomitant therapy.RESULTS In the early phase of treatment,6 patients had gradeⅢ-Ⅳgastrointestinal toxicity,2 patients had gradeⅢ-Ⅳhematologic toxicity,and 1 patient had gradeⅤtoxicity due to postoperative sepsis during chemotherapy.Only 1 patient had radiotherapy-related late side effects,i.e.,gradeⅣtenesmus.Complete pathological response was achieved in 6 patients(21%),while near-complete pathological response was obtained in 9(31%).After a median follow-up period of 60 mo,the local tumor control rate was 96.6%.In 13 patients,distant metastasis occurred.Disease-free survival rates at 2 and 5 years were 63.3%and 53%,and corresponding overall survival rates were 70%and 53.1%,respectively.CONCLUSION Although it has excellent local control and complete pathological response rates,neoadjuvant HART concurrent chemotherapy appears to not be a feasible treatment regimen in locally advanced rectal cancer,having high perioperative complication and intolerable side effects.Effects of reduced 5-fluorouracil dose or omission of chemotherapy with the aim of reducing toxicity may be examined in further studies.展开更多
文摘AIM To evaluate the efficacy and tolerability of neoadjuvant hyperfractionated accelerated radiotherapy(HART)and concurrent chemotherapy in patients with locally advanced infraperitoneal rectal cancer.METHODS A total of 30 patients with histopathologically confirmed T2-3/N0+infraperitoneal adenocarcinoma of rectum cancer patients received preoperative 42 Gy/1.5 Gy/18 days/bid radiotherapy and continuous infusion of 5-fluorouracil(325 mg/m^2).All patients were operated 4-8 wk after neoadjuvant concomitant therapy.RESULTS In the early phase of treatment,6 patients had gradeⅢ-Ⅳgastrointestinal toxicity,2 patients had gradeⅢ-Ⅳhematologic toxicity,and 1 patient had gradeⅤtoxicity due to postoperative sepsis during chemotherapy.Only 1 patient had radiotherapy-related late side effects,i.e.,gradeⅣtenesmus.Complete pathological response was achieved in 6 patients(21%),while near-complete pathological response was obtained in 9(31%).After a median follow-up period of 60 mo,the local tumor control rate was 96.6%.In 13 patients,distant metastasis occurred.Disease-free survival rates at 2 and 5 years were 63.3%and 53%,and corresponding overall survival rates were 70%and 53.1%,respectively.CONCLUSION Although it has excellent local control and complete pathological response rates,neoadjuvant HART concurrent chemotherapy appears to not be a feasible treatment regimen in locally advanced rectal cancer,having high perioperative complication and intolerable side effects.Effects of reduced 5-fluorouracil dose or omission of chemotherapy with the aim of reducing toxicity may be examined in further studies.
